Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083379 · ClinicalTrials.gov registry record · NA
Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy
A NA study of Ventilation and Atelectasis, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03083379: Completed NA study of Ventilation and Atelectasis, sponsored by University of Virginia.
NCT03083379 is a NA study of Ventilation and Atelectasis that has completed, run by University of Virginia. The registered enrollment target is 30 participants, below the 530-participant average among 4 other Ventilation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083379, a NA study of Ventilation and Atelectasis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to determine if there is a significant difference in regional distribution of ventilation when comparing eupneic tidal ventilation with Incentive Spirometry (I.S.) and EzPAP® lung expansion therapy in healthy adult human subjects. Electrical impedance tomography (EIT) will be used to measure regional distribution of ventilation during resting tidal ventilation and during lung expansion therapy.
Primary Outcome
EIT will be used to measure change in regional distribution of ventilation during lung expansion therapy.
Conditions Studied
Interventions
- DEVICE Volumetric Incentive Spirometry
- DEVICE EzPAP® POSITIVE AIRWAY PRESSURE
Study Locations (1)
Virginia
- University of Virginia Medical Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2017-04-21 |
| Phase | NA |
What the finished NCT03083379 record still lists
NCT03083379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 530-participant average among 4 other Ventilation trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Ventilation appearing as the primary indexed condition, and to 2 interventions - of which Volumetric Incentive Spirometry is the first listed.
NCT03083379 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03083379 about?
NCT03083379 is a clinical study titled "Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy". The primary purpose of this study is to determine if there is a significant difference in regional distribution of ventilation when comparing eupneic tidal ventilation with Incentive Spirometry (I.S.) and EzPAP® lung expansion therapy in healthy adult human subjects. Electrical impedance tomography ...
What is the current status of trial NCT03083379?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-03-06. Estimated completion is 2017-04-21.
What conditions does trial NCT03083379 study?
This clinical trial studies the following conditions: Ventilation, Atelectasis, Breathing.
What interventions are being tested in trial NCT03083379?
The interventions under investigation include: Volumetric Incentive Spirometry (DEVICE), EzPAP® POSITIVE AIRWAY PRESSURE (DEVICE).
Who is sponsoring clinical trial NCT03083379?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03083379 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
RECRUITING · NA
-
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
RECRUITING · NA
-
Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy
COMPLETED · NA
-
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI